Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q3 2025 Earnings Call Transcript November 4, 2025
Mirum Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.05, expectations were $-0.1.
Operator: Hello, and welcome to the Mirum Pharmaceuticals Third Quarter 2025 Financial Results and Business Update. My name is Harry, and I’ll be your operator today. [Operator Instructions] I would now like to hand the conference over to Andrew McKibben, SVP of Strategic Finance and Investor...
